304 related articles for article (PubMed ID: 9681707)
1. Myofibroblasts and the progression of crescentic glomerulonephritis.
Goumenos D; Tsomi K; Iatrou C; Oldroyd S; Sungur A; Papaioannides D; Moustakas G; Ziroyannis P; Mountokalakis T; El Nahas AM
Nephrol Dial Transplant; 1998 Jul; 13(7):1652-61. PubMed ID: 9681707
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta(1) and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease.
Goumenos DS; Tsamandas AC; Oldroyd S; Sotsiou F; Tsakas S; Petropoulou C; Bonikos D; El Nahas AM; Vlachojannis JG
Nephron; 2001 Mar; 87(3):240-8. PubMed ID: 11287759
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and myofibroblast expression in human glomerular disease: a possible link with transforming growth factor-beta-1.
Goumenos DS; Tsamandas AC; El Nahas AM; Thomas G; Tsakas S; Sotsiou F; Bonikos DS; Vlachojannis JG
Nephron; 2002 Oct; 92(2):287-96. PubMed ID: 12218305
[TBL] [Abstract][Full Text] [Related]
4. Myofibroblast phenotypes expression in experimental renal scarring.
Muchaneta-Kubara EC; el Nahas AM
Nephrol Dial Transplant; 1997 May; 12(5):904-15. PubMed ID: 9175042
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of extracellular matrix proteoglycans and collagen type I in human crescentic glomerulonephritis.
Stokes MB; Hudkins KL; Zaharia V; Taneda S; Alpers CE
Kidney Int; 2001 Feb; 59(2):532-42. PubMed ID: 11168935
[TBL] [Abstract][Full Text] [Related]
6. Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis.
Mezzano S; Droguett A; Burgos ME; Aros C; Ardiles L; Flores C; Carpio D; Carvajal G; Ruiz-Ortega M; Egido J
Nephrol Dial Transplant; 2007 Jul; 22(7):1882-90. PubMed ID: 17403698
[TBL] [Abstract][Full Text] [Related]
7. Urinary Transforming Growth Factor-beta 1 as a marker of response to immunosuppressive treatment, in patients with crescentic nephritis.
Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
BMC Nephrol; 2005 Dec; 6():16. PubMed ID: 16367998
[TBL] [Abstract][Full Text] [Related]
8. Stem cell factor and crescentic glomerulonephritis.
El Kossi MM; El Nahas AM
Am J Kidney Dis; 2003 Apr; 41(4):785-95. PubMed ID: 12666065
[TBL] [Abstract][Full Text] [Related]
9. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis.
Jinde K; Nikolic-Paterson DJ; Huang XR; Sakai H; Kurokawa K; Atkins RC; Lan HY
Am J Kidney Dis; 2001 Oct; 38(4):761-9. PubMed ID: 11576879
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta, endothelin-1, and c-fos expression in necrotizing/crescentic IgA glomerulonephritis.
Rastaldi MP; Tunesi S; Ferrario F; Indaco A; Zou H; Napodano P; D'Amico G
Nephrol Dial Transplant; 1998 Jul; 13(7):1668-74. PubMed ID: 9681709
[TBL] [Abstract][Full Text] [Related]
11. Cytokines and cell cycle regulation in the fibrous progression of crescent formation in antiglomerular basement membrane nephritis of WKY rats.
Fujigaki Y; Sun DF; Fujimoto T; Yonemura K; Morioka T; Yaoita E; Hishida A
Virchows Arch; 2001 Jul; 439(1):35-45. PubMed ID: 11499838
[TBL] [Abstract][Full Text] [Related]
12. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis.
Liu ZH; Chen SF; Zhou H; Chen HP; Li LS
Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090
[TBL] [Abstract][Full Text] [Related]
13. Fibrotic mechanisms in idiopathic rapidly progressive glomerulonephritis: the role of TGF-beta1 and C5b-9.
Gionanlis L; Alexopoulos E; Papagianni A; Leontsini M; Memmos D
Ren Fail; 2008; 30(2):239-46. PubMed ID: 18300128
[TBL] [Abstract][Full Text] [Related]
14. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation.
Ng YY; Fan JM; Mu W; Nikolic-Paterson DJ; Yang WC; Huang TP; Atkins RC; Lan HY
Nephrol Dial Transplant; 1999 Dec; 14(12):2860-72. PubMed ID: 10570089
[TBL] [Abstract][Full Text] [Related]
15. Myofibroblasts and the progression of experimental glomerulonephritis.
Zhang G; Moorhead PJ; el Nahas AM
Exp Nephrol; 1995; 3(5):308-18. PubMed ID: 7583053
[TBL] [Abstract][Full Text] [Related]
16. Interstitial myofibroblasts: predictors of progression in membranous nephropathy.
Roberts IS; Burrows C; Shanks JH; Venning M; McWilliam LJ
J Clin Pathol; 1997 Feb; 50(2):123-7. PubMed ID: 9155692
[TBL] [Abstract][Full Text] [Related]
17. Roles of and correlation between alpha-smooth muscle actin, CD44, hyaluronic acid and osteopontin in crescent formation in human glomerulonephritis.
Nakamura H; Kitazawa K; Honda H; Sugisaki T
Clin Nephrol; 2005 Dec; 64(6):401-11. PubMed ID: 16370152
[TBL] [Abstract][Full Text] [Related]
18. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of tubular epithelial cells and vascular endothelial cells in glomerulonephritis.
Bob F; Gluhovschi G; Herman D; Petrica L; Bozdog G; Gluhovschi C; Velciov S; Gadalean F; Timar R; Potencz E; Dema A; Schiller A
Ren Fail; 2014 Sep; 36(8):1208-14. PubMed ID: 24946133
[TBL] [Abstract][Full Text] [Related]
20. Mast cells in rapidly progressive glomerulonephritis.
Tóth T; Tóth-Jakatics R; Jimi S; Ihara M; Urata H; Takebayashi S
J Am Soc Nephrol; 1999 Jul; 10(7):1498-505. PubMed ID: 10405205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
